Strikingly, in our series, the analysis of the circulating monocyte patterns revealed the presence of higher levels of intermediate CD14++CD16+ and nonclassical CD14+CD16++ cardiovascular risk monocyte phenotypes in CS patients; among them, the highest levels of atypical monocytes were observed in ACTH-independent CS patients. This evidence concerns the gene CD14 and Cowden syndrome 1.